chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Seizure like phenomena
Clinical narrative: R56.9 - Seizure-like activity (CMS/HCC)
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Hypopnoea, Inappropriate schedule of product administration, Pericarditis
Clinical narrative: Pericarditis; Pain in their chest; shallow breathing; Fever; Chills; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of PERICARDITIS (Pericarditis) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047a21a and 037b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Molluscum contagiosum ('triamcinolone acetonide'  as treatment) since 02-Apr-2021. Concomitant products included EZETIMIBE, PANTOPRAZOLE, IBUPROFEN and COLCHICINE for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 11-May-2021, the patient experienced PERICARDITIS (Pericarditis) (seriousness criteria hospitalization and medically significant) and CHEST PAIN (Pain in their chest). 11-May-2021, the patient experienced HYPOPNOEA (shallow breathing). The patient was hospitalized on 11-May-2021 due to PERICARDITIS. The patient was treated with MORPHINE for Pain prophylaxis, at an unspecified dose and frequency and OXYCODONE for Shallow breathing, at an unspecified dose and frequency. On 20-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, PERICARDITIS (Pericarditis), CHEST PAIN (Pain in their chest), HYPOPNOEA (shallow breathing), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. Treatment medications included morphine and oxycodone.  Company comments: This report refers to a case of inappropriate schedule of product administration for mRNA-1273 (lot # 037b21a) with AEs of Pericarditis, Chest pain, Hypopnoea, Pyrexia and Chills reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.   This case was linked to MOD-2021-177226 (Patient Link).; Sender's Comments: This report refers to a case of inappropriate schedule of product administration for mRNA-1273 (lot # 037b21a) with AEs of Pericarditis, Chest pain, Hypopnoea, Pyrexia and Chills reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Pericarditis; Pain in their chest; shallow breathing; Fever; Chills; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of PERICARDITIS (Pericarditis) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047a21a and 037b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Molluscum contagiosum ('triamcinolone acetonide'  as treatment) since 02-Apr-2021. Concomitant products included EZETIMIBE, PANTOPRAZOLE, IBUPROFEN and COLCHICINE for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 21-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever) and CHILLS (Chills). On 11-May-2021, the patient experienced PERICARDITIS (Pericarditis) (seriousness criteria hospitalization and medically significant) and CHEST PAIN (Pain in their chest). 11-May-2021, the patient experienced HYPOPNOEA (shallow breathing). The patient was hospitalized on 11-May-2021 due to PERICARDITIS. The patient was treated with MORPHINE for Pain prophylaxis, at an unspecified dose and frequency and OXYCODONE for Shallow breathing, at an unspecified dose and frequency. On 20-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, PERICARDITIS (Pericarditis), CHEST PAIN (Pain in their chest), HYPOPNOEA (shallow breathing), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable. Treatment medications included morphine and oxycodone.  Company comments: This report refers to a case of inappropriate schedule of product administration for mRNA-1273 (lot # 037b21a) with AEs of Pericarditis, Chest pain, Hypopnoea, Pyrexia and Chills reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.   This case was linked to MOD-2021-177226 (Patient Link).; Sender's Comments: This report refers to a case of inappropriate schedule of product administration for mRNA-1273 (lot # 037b21a) with AEs of Pericarditis, Chest pain, Hypopnoea, Pyrexia and Chills reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: I experienced moderate to severe heart pain. It was stabbing and seemed to occur more with movement.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Vaccine Administration Error.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Decreased appetite, Diarrhoea, Full blood count
Clinical narrative: A few hours after receiving the vaccine on 6/2/2021, patient developed a low-grade temp. Then through the night he started having nausea, vomiting, and diarrhea which worsened on 6/3/2021. He had very poor appetite and very poor oral intake.  Within 24 hours of receiving vaccine,  he developed hypoxia and required 4L via NC to maintain an oxygen saturation in the low 90s. Stat CXR was obtained on 6/3/2021 with no acute findings. Patient received phenergan 12.5mg IM injection X 1 which did improve nausea and vomiting. Diarrhea continued. Patient has poor urine output. Tachycardia with pulse of 122, BP 118/62.   Patient was seen for an acute visit by this NP on 6/4/2021.  Patient is lethargic but does awaken to tactile stimuli. He tolerates PO fluids. He is lethargic. Stat labs obtained for concerns of dehydration.  Will plan to order IV fluids for hydration after reviewing lab results.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Nausea, Pyrexia, Tachycardia, Urine analysis
Clinical narrative: A few hours after receiving the vaccine on 6/2/2021, patient developed a low-grade temp. Then through the night he started having nausea, vomiting, and diarrhea which worsened on 6/3/2021. He had very poor appetite and very poor oral intake.  Within 24 hours of receiving vaccine,  he developed hypoxia and required 4L via NC to maintain an oxygen saturation in the low 90s. Stat CXR was obtained on 6/3/2021 with no acute findings. Patient received phenergan 12.5mg IM injection X 1 which did improve nausea and vomiting. Diarrhea continued. Patient has poor urine output. Tachycardia with pulse of 122, BP 118/62.   Patient was seen for an acute visit by this NP on 6/4/2021.  Patient is lethargic but does awaken to tactile stimuli. He tolerates PO fluids. He is lethargic. Stat labs obtained for concerns of dehydration.  Will plan to order IV fluids for hydration after reviewing lab results.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Urine output decreased, Vomiting
Clinical narrative: A few hours after receiving the vaccine on 6/2/2021, patient developed a low-grade temp. Then through the night he started having nausea, vomiting, and diarrhea which worsened on 6/3/2021. He had very poor appetite and very poor oral intake.  Within 24 hours of receiving vaccine,  he developed hypoxia and required 4L via NC to maintain an oxygen saturation in the low 90s. Stat CXR was obtained on 6/3/2021 with no acute findings. Patient received phenergan 12.5mg IM injection X 1 which did improve nausea and vomiting. Diarrhea continued. Patient has poor urine output. Tachycardia with pulse of 122, BP 118/62.   Patient was seen for an acute visit by this NP on 6/4/2021.  Patient is lethargic but does awaken to tactile stimuli. He tolerates PO fluids. He is lethargic. Stat labs obtained for concerns of dehydration.  Will plan to order IV fluids for hydration after reviewing lab results.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy liver, Blood bilirubin, Chromaturia, Hepatitis, Jaundice
Clinical narrative: but his liver had inflammation; jaundiced; dark urine; He did not receive second injection of the moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HEPATITIS (but his liver had inflammation) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (He did not receive second injection of the moderna vaccine). On 30-Mar-2021, the patient experienced CHROMATURIA (dark urine). On 01-Apr-2021, the patient experienced JAUNDICE (jaundiced). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEPATITIS (but his liver had inflammation) (seriousness criterion medically significant). The patient was treated with PREDNISONE ongoing since an unknown date for Liver inflammation, at an unspecified dose and frequency. On 27-Mar-2021, PRODUCT DOSE OMISSION ISSUE (He did not receive second injection of the moderna vaccine) had resolved. At the time of the report, HEPATITIS (but his liver had inflammation), CHROMATURIA (dark urine) and JAUNDICE (jaundiced) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Biopsy liver: (abnormal) cancer free but liver had inflammation.. On 06-Apr-2021, Blood bilirubin: 36 (High) 36. On an unknown date, Blood bilirubin: 26 (Inconclusive) 26.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. On 30-Mar-2021, patient stated that his urine was getting dark and two days later, he started looking jaundiced. Patient saw the doctor on 06-Apr-2021. He was started on 20mg per day of prednisone. Company comment: Very limited information regarding this event has been provided at this time. Further information has been  requested. This is also a case of a 83 year old male who missed dose as a result of experienced illness.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been  requested. This is also a case of a 83 year old male who missed dose as a result of experienced illness.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: but his liver had inflammation; jaundiced; dark urine; He did not receive second injection of the moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HEPATITIS (but his liver had inflammation) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (He did not receive second injection of the moderna vaccine). On 30-Mar-2021, the patient experienced CHROMATURIA (dark urine). On 01-Apr-2021, the patient experienced JAUNDICE (jaundiced). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEPATITIS (but his liver had inflammation) (seriousness criterion medically significant). The patient was treated with PREDNISONE ongoing since an unknown date for Liver inflammation, at an unspecified dose and frequency. On 27-Mar-2021, PRODUCT DOSE OMISSION ISSUE (He did not receive second injection of the moderna vaccine) had resolved. At the time of the report, HEPATITIS (but his liver had inflammation), CHROMATURIA (dark urine) and JAUNDICE (jaundiced) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Biopsy liver: (abnormal) cancer free but liver had inflammation.. On 06-Apr-2021, Blood bilirubin: 36 (High) 36. On an unknown date, Blood bilirubin: 26 (Inconclusive) 26.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. On 30-Mar-2021, patient stated that his urine was getting dark and two days later, he started looking jaundiced. Patient saw the doctor on 06-Apr-2021. He was started on 20mg per day of prednisone. Company comment: Very limited information regarding this event has been provided at this time. Further information has been  requested. This is also a case of a 83 year old male who missed dose as a result of experienced illness.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been  requested. This is also a case of a 83 year old male who missed dose as a result of experienced illness.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Photophobia
Clinical narrative: Strong headache and poor tolerance to exposure to natural and artificial light.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Vaccine Administration Error
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site inflammation, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Inflammation, heat, itchiness, tenderness at injection site. 2in in diameter onset 1 week post injection
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Crying, Diarrhoea, Hypopnoea
Clinical narrative: I became very sick with fever at 3am.  I was vomiting and diarrhea at the same time for hours. I was weak, had a fever of 101, my heart was racing and my breathing shallow.  This went on for hours.  24 hours later body aches, stomach hurts, temp 100. 36 hours later body aches, crying
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pain, Palpitations, Pyrexia, Vomiting
Clinical narrative: I became very sick with fever at 3am.  I was vomiting and diarrhea at the same time for hours. I was weak, had a fever of 101, my heart was racing and my breathing shallow.  This went on for hours.  24 hours later body aches, stomach hurts, temp 100. 36 hours later body aches, crying
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Arthralgia, Blood test normal, Catheterisation cardiac, Chest X-ray normal
Clinical narrative: Chest pain, tachycardia, pain radiating to scapular and shoulder pain , fatigue and shortness of breath over day 2 after vaccine worsened by day 6 ended in urgent care-EKG with st and t waves changes. Referred to emergency room and admitted at cardiac cath. unit-required emergency.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram thorax normal, Dyspnoea, Electrocardiogram ST segment depression, Electrocardiogram ST segment elevation
Clinical narrative: Chest pain, tachycardia, pain radiating to scapular and shoulder pain , fatigue and shortness of breath over day 2 after vaccine worsened by day 6 ended in urgent care-EKG with st and t waves changes. Referred to emergency room and admitted at cardiac cath. unit-required emergency.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram T wave abnormal, Fatigue, Myocardial necrosis marker normal, Pain, Tachycardia
Clinical narrative: Chest pain, tachycardia, pain radiating to scapular and shoulder pain , fatigue and shortness of breath over day 2 after vaccine worsened by day 6 ended in urgent care-EKG with st and t waves changes. Referred to emergency room and admitted at cardiac cath. unit-required emergency.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood test, Dehydration, Dyspnoea, Renal disorder
Clinical narrative: I was at work and feeling sluggish and couldn't hardly breathe. I went to the hospital and was told my kidneys were failing and my blood pressure was dropping lower and lower. My kidneys were dehydrated and I needed to get fluids.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Renal failure, Sluggishness, Ultrasound scan
Clinical narrative: I was at work and feeling sluggish and couldn't hardly breathe. I went to the hospital and was told my kidneys were failing and my blood pressure was dropping lower and lower. My kidneys were dehydrated and I needed to get fluids.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Vaccine Administration Error
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, C-reactive protein, C-reactive protein normal, Full blood count, Full blood count normal
Clinical narrative: diffuse severe myalgias, arthralgias, starting 2 days after vaccine administration, and progressive through current day. Patient evaluated today in clinic, and symptoms are increasing. No fevers, chills, but diffuse muscle tenderness and guarding with range motion shoulders and hips
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Metabolic function test, Myalgia, Red blood cell sedimentation rate, Red blood cell sedimentation rate normal
Clinical narrative: diffuse severe myalgias, arthralgias, starting 2 days after vaccine administration, and progressive through current day. Patient evaluated today in clinic, and symptoms are increasing. No fevers, chills, but diffuse muscle tenderness and guarding with range motion shoulders and hips
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray limb normal, X-ray of pelvis and hip normal
Clinical narrative: diffuse severe myalgias, arthralgias, starting 2 days after vaccine administration, and progressive through current day. Patient evaluated today in clinic, and symptoms are increasing. No fevers, chills, but diffuse muscle tenderness and guarding with range motion shoulders and hips
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Fatigue, Feeling abnormal, Pyrexia, Vertigo
Clinical narrative: I made sure to stay very hydrated before and after my vaccine and took an extra strength Tylenol right after. That evening I was tired and had a bit of a fever, but felt fine.  The following days were fine, except I was under a lot of stress at work and on the 3rd day I flew to  for a Bachelorette party weekend where I drank alcohol and stayed out a little later than usual. I get fine however. On the 5th day we spent it drinking on a boat and after leaving the boat exhaustion and the vertigo of being on a boat never left. I?ve been feeling this way since May 15 and it is now June 4. I?ve seen an ENT that thought it might be allergy related so I was tested for that, but I?m fine. I?m awaiting a full panel of blood test results from my Functional Doctor. Rest, relaxation haven?t helped. I?ve had brain fog, exhaustion and vertigo for almost 3 weeks now.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Appetite disorder, Fatigue, Hypersomnia, Nausea, Sleep disorder
Clinical narrative: Day 1 Nausea & Vomiting extreme fatigue, Day 2 Slept all day and fitfully through night. 2.  Slept all day,  no food consumed, water in huge amount. Day3. Diarrhea, slept again most of day and did eat lightly. Day 4. fell normal but tied and sleepy buy less so than previous.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vomiting
Clinical narrative: Day 1 Nausea & Vomiting extreme fatigue, Day 2 Slept all day and fitfully through night. 2.  Slept all day,  no food consumed, water in huge amount. Day3. Diarrhea, slept again most of day and did eat lightly. Day 4. fell normal but tied and sleepy buy less so than previous.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Brain natriuretic peptide normal, Chest X-ray normal, Chills, Dyspnoea
Clinical narrative: Pt report normal flu like illness, fever, chills and headache for 3 days after vaccination.  About 2 week prior to her second dose scheduled she developed dyspnea on exertion, and low back pain, and shortness of breath, which she attributes to COVID vaccination.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea exertional, Fibrin D dimer normal, Full blood count normal, Headache, Influenza like illness
Clinical narrative: Pt report normal flu like illness, fever, chills and headache for 3 days after vaccination.  About 2 week prior to her second dose scheduled she developed dyspnea on exertion, and low back pain, and shortness of breath, which she attributes to COVID vaccination.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Pyrexia, SARS-CoV-2 antibody test positive, Spinal X-ray abnormal
Clinical narrative: Pt report normal flu like illness, fever, chills and headache for 3 days after vaccination.  About 2 week prior to her second dose scheduled she developed dyspnea on exertion, and low back pain, and shortness of breath, which she attributes to COVID vaccination.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Hypoaesthesia, Menstruation irregular
Clinical narrative: 4/23/2021  3 days after getting vaccine, Menstrual cycle started early morning, after NOT having a period since JULY 7, 2020. Very heavy bleeding.  5/8/2021 Big Toe on right foot feels numb, asleep  5/15/2021 Left hand, index finger  started feeling numb. Still having issues with both toe and finger.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: I began experiencing tinnitus in both ears constantly which I've never experienced before.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Incomplete course of vaccination, Lymphadenopathy, Musculoskeletal stiffness, Neck pain, Swelling
Clinical narrative: On 12/20/20 i had received the Moderna covid vaccination.  3 days after i had recieved the vaccination i had felt like i had a stiff neck on the same side of my body that i receive the vaccination on. I had just ignored it until i noticed a "bump" on the side of my neck. I felt it and felt a large swollen lymph node. Again I had decided to ignore the reaction as i figured my antibodies were at work. I had decided to not get the second dose 28 days later as the lymph node had not gone down yet. It is now 06.04.2021 and the lymph node is still there, at this point it is causing an uncomfortable pain in my neck as it is growing.  I would like a letter stating i am medically except from receiving the second vaccination in order to fly.  Thank You.
Sex: M
Vaccine: COVID19
Symptoms: Lymphoma
Clinical narrative: Lymphoma; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOMA (Lymphoma) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHOMA (Lymphoma) (seriousness criterion medically significant). At the time of the report, LYMPHOMA (Lymphoma) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication not reported.  Treatment medication not reported.  Company comment: Based on reporter's causality (Lymphoma caused by Covid-19 vaccine) the event is assessed as unlikely related to mRNA-1273.; Sender's Comments: Based on reporter's causality (Lymphoma caused by Covid-19 vaccine) the event is assessed as unlikely related to mRNA-1273.
Sex: U
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Swelling
Clinical narrative: Developed a red, slightly raised rash on the arm that was injected.  Not itchy, not painful.  It was roughly 3x3 inches, sort of heart shaped, homogenous and not at the injection site, but rather between my elbow and shoulder.  It disappeared within 36 hours with no further recurrence.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Rash, Rash macular, Rash papular
Clinical narrative: Patient was seen in office 6/3/2021 with complaints of a site reaction to the COVID-19 vaccine; arm swelling near the site and warm to the touch
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Feeling abnormal, Headache, Lymphadenopathy
Clinical narrative: Day 7: swollen lymph node in left armpit. Day 8-10: headache fever, chills  Day 11: head ache, space feeling,  blotchy skin  Day 12: severe headache, hives down legs to toes and back of arms with tingling burning sensation.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pyrexia, Rash macular, Urticaria
Clinical narrative: Day 7: swollen lymph node in left armpit. Day 8-10: headache fever, chills  Day 11: head ache, space feeling,  blotchy skin  Day 12: severe headache, hives down legs to toes and back of arms with tingling burning sensation.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Vaccine Administration Error
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Burning sensation, Erythema, Gait disturbance, Peripheral swelling
Clinical narrative: Legs began to blister; Felt like a sunburn from inside out; legs look like raw meat; Could hardly walk; Legs are still swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLISTER (Legs began to blister), BURNING SENSATION (Felt like a sunburn from inside out), ERYTHEMA (legs look like raw meat) and GAIT DISTURBANCE (Could hardly walk) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced BLISTER (Legs began to blister) (seriousness criterion hospitalization), BURNING SENSATION (Felt like a sunburn from inside out) (seriousness criterion hospitalization), ERYTHEMA (legs look like raw meat) (seriousness criterion hospitalization) and GAIT DISTURBANCE (Could hardly walk) (seriousness criterion hospitalization). On an unknown date, the patient experienced PERIPHERAL SWELLING (Legs are still swollen). The patient was treated with Manual therapy (treated legs with silver pads) for Peripheral swelling. At the time of the report, BLISTER (Legs began to blister), BURNING SENSATION (Felt like a sunburn from inside out), ERYTHEMA (legs look like raw meat) and GAIT DISTURBANCE (Could hardly walk) outcome was unknown and PERIPHERAL SWELLING (Legs are still swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated her legs began to blister, felt like a sunburn from the inside out. Patient states legs look like raw meat and she could hardly walk. The patient was admitted to hospital for an overnight stay. The patient stated to physician treated legs with silver pads and antibiotics. The patient stated she was due to visit physician on 03-Jun-2021 for a check up. The patient stated she was wearing compression socks on both legs currently and legs were still swollen.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: Injection site displaying  red circular mark on skin, even as of today 06/04/2021 Site is pain free, and arm is fully functional.  no pain in arm. no other adverse affects from shot
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: Presented with clots; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Presented with clots) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milligram. On an unknown date, the patient experienced THROMBOSIS (Presented with clots) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (Presented with clots) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  Company comment: Very limited information regarding this event has been provided at this time.  Further information cannot be requested.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information cannot be requested.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral normal, Anxiety, Blood test normal, Computerised tomogram head abnormal, Dizziness
Clinical narrative: PT STARTED EXPERIENCING INTENSE HEADACHES ON THE MORNING OF 5/21/2021. THE HEADACHES CONTINUED ON AND OFF FOR SEVERAL DAYS UNTIL ON 5/24/2021 AT 3 PM, SHE HAD A DEBILITATING HEADACHE WITH DIZZINESS THAT COULD NOT BE RELIEVED. THEN ON THE AFTERNOON OF 5/25/2021, SHE STARTED EXPERIENCING VISUAL CHANGES WITH BLACK SPOTS IN HER VISION. SHE WAS ABLE TO SEE HER DOCTOR ON 5/27/2021 AT 10 AM. HE SENT HER FOR A CT SCAN OF HER HEAD WHICH WAS FOLLOWED BY A MRI OF HER BRAIN. THE MRI AND CT SCAN REVEALED THAT SHE HAD A LEFT FRONTAL ISCHEMIC STROKE. SHE WAS ADMITTED TO THE HOSPITAL ON 5/27 AND DISCHARGED HOME ON THE AFTERNOON OF 5/28. SHE HAD A CT ANGIOGRAM OF THE BRAIN, AN ECHO OF THE HEART, ULTRASOUND OF THE CAROTIDS AND A HYPERCOAGULATION BLOOD PANEL. ALL OF WHICH WERE NORMAL AND SHOWED NO EVIDENCE OF WHERE THE BLOOD CLOTS CAME FROM THAT CAUSED HER STROKE.  SHE CONTINUES TO HAVE HEADACHES WITH DIZZINESS, FATIGUE, AND NOW BAD ANXIETY.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram normal, Fatigue, Full blood count normal, Headache, Ischaemic stroke
Clinical narrative: PT STARTED EXPERIENCING INTENSE HEADACHES ON THE MORNING OF 5/21/2021. THE HEADACHES CONTINUED ON AND OFF FOR SEVERAL DAYS UNTIL ON 5/24/2021 AT 3 PM, SHE HAD A DEBILITATING HEADACHE WITH DIZZINESS THAT COULD NOT BE RELIEVED. THEN ON THE AFTERNOON OF 5/25/2021, SHE STARTED EXPERIENCING VISUAL CHANGES WITH BLACK SPOTS IN HER VISION. SHE WAS ABLE TO SEE HER DOCTOR ON 5/27/2021 AT 10 AM. HE SENT HER FOR A CT SCAN OF HER HEAD WHICH WAS FOLLOWED BY A MRI OF HER BRAIN. THE MRI AND CT SCAN REVEALED THAT SHE HAD A LEFT FRONTAL ISCHEMIC STROKE. SHE WAS ADMITTED TO THE HOSPITAL ON 5/27 AND DISCHARGED HOME ON THE AFTERNOON OF 5/28. SHE HAD A CT ANGIOGRAM OF THE BRAIN, AN ECHO OF THE HEART, ULTRASOUND OF THE CAROTIDS AND A HYPERCOAGULATION BLOOD PANEL. ALL OF WHICH WERE NORMAL AND SHOWED NO EVIDENCE OF WHERE THE BLOOD CLOTS CAME FROM THAT CAUSED HER STROKE.  SHE CONTINUES TO HAVE HEADACHES WITH DIZZINESS, FATIGUE, AND NOW BAD ANXIETY.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Metabolic function test normal, Thrombosis, Ultrasound Doppler, Ultrasound scan normal
Clinical narrative: PT STARTED EXPERIENCING INTENSE HEADACHES ON THE MORNING OF 5/21/2021. THE HEADACHES CONTINUED ON AND OFF FOR SEVERAL DAYS UNTIL ON 5/24/2021 AT 3 PM, SHE HAD A DEBILITATING HEADACHE WITH DIZZINESS THAT COULD NOT BE RELIEVED. THEN ON THE AFTERNOON OF 5/25/2021, SHE STARTED EXPERIENCING VISUAL CHANGES WITH BLACK SPOTS IN HER VISION. SHE WAS ABLE TO SEE HER DOCTOR ON 5/27/2021 AT 10 AM. HE SENT HER FOR A CT SCAN OF HER HEAD WHICH WAS FOLLOWED BY A MRI OF HER BRAIN. THE MRI AND CT SCAN REVEALED THAT SHE HAD A LEFT FRONTAL ISCHEMIC STROKE. SHE WAS ADMITTED TO THE HOSPITAL ON 5/27 AND DISCHARGED HOME ON THE AFTERNOON OF 5/28. SHE HAD A CT ANGIOGRAM OF THE BRAIN, AN ECHO OF THE HEART, ULTRASOUND OF THE CAROTIDS AND A HYPERCOAGULATION BLOOD PANEL. ALL OF WHICH WERE NORMAL AND SHOWED NO EVIDENCE OF WHERE THE BLOOD CLOTS CAME FROM THAT CAUSED HER STROKE.  SHE CONTINUES TO HAVE HEADACHES WITH DIZZINESS, FATIGUE, AND NOW BAD ANXIETY.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual impairment
Clinical narrative: PT STARTED EXPERIENCING INTENSE HEADACHES ON THE MORNING OF 5/21/2021. THE HEADACHES CONTINUED ON AND OFF FOR SEVERAL DAYS UNTIL ON 5/24/2021 AT 3 PM, SHE HAD A DEBILITATING HEADACHE WITH DIZZINESS THAT COULD NOT BE RELIEVED. THEN ON THE AFTERNOON OF 5/25/2021, SHE STARTED EXPERIENCING VISUAL CHANGES WITH BLACK SPOTS IN HER VISION. SHE WAS ABLE TO SEE HER DOCTOR ON 5/27/2021 AT 10 AM. HE SENT HER FOR A CT SCAN OF HER HEAD WHICH WAS FOLLOWED BY A MRI OF HER BRAIN. THE MRI AND CT SCAN REVEALED THAT SHE HAD A LEFT FRONTAL ISCHEMIC STROKE. SHE WAS ADMITTED TO THE HOSPITAL ON 5/27 AND DISCHARGED HOME ON THE AFTERNOON OF 5/28. SHE HAD A CT ANGIOGRAM OF THE BRAIN, AN ECHO OF THE HEART, ULTRASOUND OF THE CAROTIDS AND A HYPERCOAGULATION BLOOD PANEL. ALL OF WHICH WERE NORMAL AND SHOWED NO EVIDENCE OF WHERE THE BLOOD CLOTS CAME FROM THAT CAUSED HER STROKE.  SHE CONTINUES TO HAVE HEADACHES WITH DIZZINESS, FATIGUE, AND NOW BAD ANXIETY.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Cardiolipin antibody negative, Deep vein thrombosis, Fall, Joint injury
Clinical narrative: On May 15th, she got the J&J vaccine.  Then on May 17th, while she was walking, she tripped on a curb and fell and then landed on her left knee.  Then, this past Thursday on May 20th, she noticed swelling and pain in the left leg.  She presented to urgent care the following day on Friday and had an ultrasound done that revealed blood clot in the superficial veins.  Patient recalls of had a similar episode of superficial vein clot about 6 years ago. Referred to vascular and second ultrasound done revealing DVT
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Thrombophlebitis superficial, Ultrasound scan abnormal
Clinical narrative: On May 15th, she got the J&J vaccine.  Then on May 17th, while she was walking, she tripped on a curb and fell and then landed on her left knee.  Then, this past Thursday on May 20th, she noticed swelling and pain in the left leg.  She presented to urgent care the following day on Friday and had an ultrasound done that revealed blood clot in the superficial veins.  Patient recalls of had a similar episode of superficial vein clot about 6 years ago. Referred to vascular and second ultrasound done revealing DVT
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Myalgia, Polymyalgia rheumatica
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of POLYMYALGIA RHEUMATICA (acute polymyalgia rheumatica) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced POLYMYALGIA RHEUMATICA (acute polymyalgia rheumatica) (seriousness criterion medically significant), MOBILITY DECREASED (couldn't reach her arms out,thighs would not move), MYALGIA (couldn't get out of bed from pain) and ARTHRALGIA (pain in her shoulders,pain in her hip area). The patient was treated with PREDNISONE for Polymyalgia rheumatica, at a dose of 40 milligram; PREDNISONE for Polymyalgia rheumatica, at a dose of 20 milligram and PREDNISONE for Polymyalgia rheumatica, at a dose of 10 milligram. At the time of the report, POLYMYALGIA RHEUMATICA (acute polymyalgia rheumatica), MOBILITY DECREASED (couldn't reach her arms out,thighs would not move), MYALGIA (couldn't get out of bed from pain) and ARTHRALGIA (pain in her shoulders,pain in her hip area) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  Patient's physician started her with Prednisone 40 mg, then down to 20mg and then 10mg, but the polymyaligia came back so she had to increase the prednisone. Patient reports that she felt better, and the 20 mg seem to be working. The patient did not had this type of complication in the past. Patient's physician stated to take therapy for 6 weeks and then to run more tests. Antinuclear antibody (ANA) titer was high, indicating Lupus. EFR (as reported) high at 27, White blood cell (WBC) was 12.8 but did not had any symptoms of cold or flu. Mean Corpuscular Haemoglobin (MCH) was 41.3 and Liposides were 3.5.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, medical history and concomitant medication details are required for further assessment.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, medical history and concomitant medication details are required for further assessment.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal, Vertigo
Clinical narrative: Vertigo, dizziness, lightheaded.  Start 10 days after 2nd shot and still continues today.   It happens when I lay down, when I stit up in the morning and can happen anytime during the day. I feel like I am in a fog all day!!!
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Disturbance in attention, Dizziness, Fatigue, Feeling abnormal, Headache
Clinical narrative: Vertigo, dizziness, lightheaded.  Start 10 days after 2nd shot and still continues today.   It happens when I lay down, when I stit up in the morning and can happen anytime during the day. I feel like I am in a fog all day!!!
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Died) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant medications were reported.  No treatment information was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable. Company comment: Very limited information regarding this patient's death has been provided at this time.; Sender's Comments: Very limited information regarding this patient's death has been provided at this time.; Reported Cause(s) of Death: Death
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, C-reactive protein increased, Chest discomfort, Electrocardiogram abnormal, Fatigue
Clinical narrative: My son developed severe fatigue, muscle aches, fainting, headache, tachycardia for 1 week (up to 164 in the ED), fever, feelings of chest heaviness.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Myalgia, Neutrophil count increased, Pyrexia
Clinical narrative: My son developed severe fatigue, muscle aches, fainting, headache, tachycardia for 1 week (up to 164 in the ED), fever, feelings of chest heaviness.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Syncope, Tachycardia, White blood cell count increased
Clinical narrative: My son developed severe fatigue, muscle aches, fainting, headache, tachycardia for 1 week (up to 164 in the ED), fever, feelings of chest heaviness.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: After administration of the Moderna vaccine on 5/28/21, the patient reported having already previously received a Pfizer vaccine on 4/22/21. Dr. called the CDC for advice on how to proceed and was advised that we needed to report this as an adverse event. The patient has not presented any adverse signs or symptoms.
Age: 1.25
Sex: F
Vaccine: DTAP, HEP, PNC13
Symptoms: Wrong product administered
Clinical narrative: Hep B not due, given instead of hep A
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Gamma-glutamyltransferase increased
Clinical narrative: Marked increase/ worsening of his liver labs between 3/17/21 and the next time they were checked on 5/25/21. Patient had two doses of Pfizer COVID-19 vaccine during that time .  First dose was on 4/3/21 EP7533. Second dose was on 5/1/21 ER8736.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain
Clinical narrative: Sharp stabbing pain/throbbing under left breast.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness
Clinical narrative: This spontaneous case was reported by an other caregiver (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 032M20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included METFORMIN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced DIZZINESS (Dizziness) (seriousness criteria hospitalization and medically significant). The patient was treated with CARVEDILOL ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 220/140 (High) Blood pressure was recorded as 200/140 in emergency.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Fainting; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Fainting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SYNCOPE (Fainting) (seriousness criterion medically significant). At the time of the report, SYNCOPE (Fainting) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Pain in extremity, Visual impairment, Vomiting
Clinical narrative: She got her vaccine, nothing happened after the first 15 minutes, everything was fine.  Her arm was sore for about 2 1/2 days and then 4 days later she was nauseous, had vomiting, and that next morning and ever since she has had a terrible migraine.  Her vision has either started to swirl and miss some spots in her vision, and then migraine pain and nausea that starts shortly after that.   She has not gone to her doctor for her symptoms.  She has taken Tylenol, Excedrin, and a Goodies powder with some relief, but they have not relieved the pain entirely.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Chest pain, Condition aggravated, Erythema, Fatigue
Clinical narrative: On the third day after the injection,  I had a sudden return of sx previously experienced with medications cleared  3A4/5 and 2C19 including rigid paralysis for >11 minutes,  multiple contractions, numbness/tingling in legs. I had not experienced any of these symptoms for > 3 months.      Also fibromyalgia sx exacerbated to include burning pain in L arm (injection site) For 1 week, my arm turned red, like sunburn and burned.  After week 1, there was no redness but there was more pain than burning and that continued for about 4 weeks. This has since abated. I currently have extreme fatigue, fibromyalgia pain in multiple sites, esp breast, chest and legs.  Numbness and tingling continues in my feet and legs.  I am also experiencing transient numbness in my lower face, periods of severe "brain fog" (this seems to be improving) and GERD sx relieved by antacids.